StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) SEC filings

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$46.56−0.54 (-1.15%)

Close on Nov 16, 2026Market cap $1.66BP/E –Yield –

SEC filings

12 of First Tracks Biotherapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 3, 2026SEC EDGAR
Current report8-KNov 3, 2026Nov 3, 2026SEC EDGAR
Current report8-KOct 19, 2026Oct 20, 2026SEC EDGAR
Current report8-KOct 15, 2026Oct 15, 2026SEC EDGAR
Current report8-KOct 12, 2026Oct 13, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 12, 2026SEC EDGAR
Current report8-KAug 12, 2026Aug 12, 2026SEC EDGAR
Current report8-KJun 15, 2026Jun 22, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Current report8-KApr 20, 2026Apr 20, 2026SEC EDGAR
Current report8-KApr 1, 2026Apr 3, 2026SEC EDGAR

See a number that looks wrong?